Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICG Enterprise Trust Regulatory News (ICGT)

Share Price Information for ICG Enterprise Trust (ICGT)

Share Price is delayed by 15 minutes
Get Live Data
1,394.00    4.00 (0.29%)
Bid:
1,394.00
Ask:
1,412.00
Spread: 18.00 (1.291%)
Market Cap: £848.32m
ICGT Live PriceLast checked at - London Stock Exchange

Intraday ICG Enterprise Trust Share Chart

Interim Management Statement

19 Nov 2008 13:21

RNS Number : 4971I
Graphite Enterprise Trust PLC
19 November 2008
 



GRAPHITE ENTERPRISE TRUST PLC

INTERIM MANAGEMENT STATEMENT

QUARTER ENDED 30 SEPTEMBER 2008

 

Graphite Enterprise Trust PLC ('Graphite Enterprise' or 'the Company') presents its Interim  Management  Statement for the quarter ended 30 September 2008. This is the Company's second interim management statement for the financial year ending 31 December 2008, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

Investment objective

The objective of Graphite Enterprise is to provide shareholders with long term capital growth through investment in unquoted companies, mostly through specialist funds but also directly.

Unaudited net asset value per share 

The unaudited net asset value per share as at 30 September 2008 was 511.3p. This represents a fall of 1.8from the level at 30 June 2008. On 3 November, the Company announced that it had exchanged contracts to sell interests in ten funds (the "Interests") to funds managed by AlpInvest Partners NV. The effect of this is set out later in this statement.

Share price and discount

The share price fell by 15.5to 355.0p in the period from 30 June to 30 SeptemberThis compares with a fall of 13.0% in the FTSE All-Share Index in the same period. The discount to the net asset value per share increased from 19.3% to 30.6%.

Since the quarter end stock markets have been volatile. Listed private equity share prices have fallen sharply and discounts to net asset values have widened significantly. Graphite Enterprise has not been immune from these developments and its share price and discount to net asset value have followed these trends.

The share price at the close of business on 18 November was 197.0p, which was 44.5% lower than at 30 September, but 13.2% higher than immediately prior to the announcement of the sale of the Interests. The share price of 197.0p represented a discount of 61.5to the 30 September net asset value per share and at a discount of 60.2% to the pro forma net asset value per share adjusted for the sale of the Interests (see below).

  Balance sheet

The summary balance sheet as at 30 September 200(excluding the effect of the sale of the Interests) is set out below:

 
£m
% of total assets
Fund investments
252.1
66.4%
Direct investments
49.2
12.9%
Total portfolio
301.3
79.3%
Cash and near cash
78.7
20.7%
Total assets
380.0
100.0%
Net asset value per share
511.3p
 

 

The investment portfolio accounted for 79.3% of total assets at 30 September 2008 (72.4% at 30 June 2008). On 18 November cash and near cash was £75.2 million.

Valuations

The investment portfolio has been valued using the latest available managers' reports, with 33.8by value based on managers' reports as at 30 September. The great majority of the remaining portfolio has been valued using managers' reports as at 30 June as subsequent reports have not yet been received.

The portfolio fell in value by 2.5% in the quarter to 30 September. The net reduction in underlying portfolio valuations of 3.0% was partially offset by the positive impact of currency movements of 0.5%.

Commitments

Outstanding commitments fell by 9.8from £346.4 million to £312.4 million during the period.  Overcommitment, the level by which commitments exceed cash and near cash, decreased to £233.7 million, or 61.5% of net assets. No new commitments were made in the quarter.

Investments and realisations

In the three months to 30 September 2008net cash invested in the investment portfolio was £28.5 million. The Company made new investments of £35.0 million, almost all of which was into funds, and the portfolio generated proceeds of £6.5 million.

Pro forma impact of sale of part of fund portfolio

On 3 November, the Company announced that it had exchanged contracts to sell interests in ten funds (the "Interests") to funds managed by AlpInvest Partners NV. The sale is expected to generate proceeds of approximately £47.1 million and to release the Company from undrawn commitments of approximately £45.2 million. The net asset value of the Interests was £60.2 million.

The sale agreement included a price adjustment mechanism under which the price would have fallen if the MXEU Europe Index had fallen below a certain level. That mechanism has not been triggered and the expected proceeds are unchanged from those set out above.

The net asset value per share and balance sheet as at 30 September do not take account of the sale of the Interests. If the transaction had occurred at 30 September, the balance sheet and commitments would have been as shown below:

 

 
£m
% of total assets
Fund investments
191.9
52.3%
Direct investments
49.2
13.4%
Total portfolio
241.1
65.7%
Cash and near cash
125.8
34.3%
Total assets
366.9
100.0%
Net asset value per share
494.5p
 
Commitments
267.2
 
Overcommitment
141.4
 
Overcommitment as % of total assets
38.5%
 

 

If the sale had completed at the quarter end it would have reduced the level of overcommitment at 30 September from 61.5% of net assets to 38.5% and would have increased cash and near cash balances from £78.7 million to £125.8 million.

The Directors are not aware of any other events or transactions which have taken place between 30 September 2008 and the date of publication of this statement which have had a material effect on the financial position of the company.

This information has not been audited or reviewed by the Company's auditors.

Enquires:

Stephen Cavell

Tim Spence

0207 825 5300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMGMMMFLVGRZM
Date   Source Headline
11th May 20237:00 amGNWICG Enterprise Trust Plc: Preliminary Results for the twelve months ended 31 January 2023
2nd May 20237:00 amGNWICG Enterprise Trust Plc: Voting Rights and Capital
28th Apr 20237:00 amGNWICG Enterprise Trust Plc: Notification of Major Holdings
20th Apr 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
13th Apr 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
3rd Apr 20237:00 amGNWICG Enterprise Trust Plc: Voting Rights and Capital
30th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
20th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
17th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
16th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
14th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
13th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
8th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
7th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
6th Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
3rd Mar 20237:00 amRNSKepler Trust Intelligence: New Research
3rd Mar 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
1st Mar 20237:00 amGNWICG Enterprise Trust Plc: Voting Rights and Capital
24th Feb 20234:05 pmEQSHardman & Co Q&A on ICG Enterprise Trust plc (ICGT): Defensive growth adding value to investors
17th Feb 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
13th Feb 20233:17 pmRNSQuotedData's Weekly News & Interview
13th Feb 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
9th Feb 20237:15 amEQSHardman & Co Research on ICG Enterprise Trust Plc (ICGT): 3Q’23: continued growth and resilience
6th Feb 20237:00 amGNWICG Enterprise Trust Plc: Portfolio update
6th Feb 20237:00 amGNWICG Enterprise Trust Plc: Notification of major holdings
2nd Feb 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
2nd Feb 20237:00 amGNWICG Enterprise Trust Plc: Q3 Update for the three months ended 31 October 2022
1st Feb 20237:00 amGNWICG Enterprise Trust Plc: Voting Rights and Capital
1st Feb 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
30th Jan 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
27th Jan 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
26th Jan 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
23rd Jan 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
20th Jan 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
19th Jan 20237:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
3rd Jan 202311:30 amGNWICG Enterprise Trust Plc: Voting Rights and Capital
16th Dec 20227:00 amGNWICG Enterprise Trust Plc: Voting Rights and Capital
8th Dec 20227:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
30th Nov 20228:00 amEQSHardman & Co Q&A on ICG Enterprise Trust: 1H’23 results – strong half year resilient outlook
25th Nov 20227:00 amGNWICG Enterprise Trust Plc: Portfolio Update - ICG Enterprise Trust makes two new direct investments
24th Nov 20227:00 amGNWICG Enterprise Trust Plc: Portfolio Update - ICG Enterprise Trust co-investing in AmeriLife
18th Nov 20227:00 amRNSKepler Trust Intelligence: New Research
17th Nov 20227:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
10th Nov 20227:15 amEQSHardman & Co Research on ICG Enterprise Trust Plc (ICGT) - 1H’23 and beyond: safe harbour in the storm
10th Nov 20227:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
20th Oct 20227:00 amGNWICG Enterprise Trust Plc: Transaction in Own Shares
13th Oct 20227:00 amGNWICG Enterprise Trust Plc: Notification of Share Transaction
12th Oct 20227:00 amGNWICG Enterprise Trust Plc: Notification of Share Transaction
11th Oct 20227:00 amGNWICG Enterprise Trust Plc: Unaudited Interim Results for the six months ended 31 July 2022
4th Oct 20227:00 amGNWICG Enterprise Trust Plc: Portfolio Update - ICG Enterprise Trust investing in KronosNet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.